Adenocarcinoma of the prostate with neuroendocrine differentiation
Adenocarcinoma of the prostate with neuroendocrine differentiation is a malignant neuroendocrine tumor of the prostate which only differs from acinar or ductal adenocarcinoma on immunohistochemistry staining.
Adenocarcinoma of the prostate with neuroendocrine differentiation is an acinar or ductal adenocarcinoma that does not feature any typical neuroendocrine morphology as e.g. nuclear molding in small cell carcinoma or peripheral palisading in prostatic large cell neuroendocrine carcinoma but is characterized by the positivity of one of three neuroendocrine markers chromogranin A, synaptophysin or CD56 1,2.
Histologically usual adenocarcinoma of the prostate with neuroendocrine differentiation is characterized by the typical features of adenocarcinoma including 3:
- neoplastic proliferation of luminal cells
- loss of basal cells
- neuroendocrine cells on immunohistochemistry stains
Immunohistochemistry stains are usually positive for at least one neuroendocrine marker as chromogranin A, synaptophysin or CD56 2. Prostate-specific antigen (PSA) is usually positive in the adenocarcinoma and variably positive in the neuroendocrine cells 2.
Imaging features of adenocarcinoma of the prostate with neuroendocrine differentiation are that of typical prostate adenocarcinoma.
Treatment and prognosis
The prognosis and treatment of adenocarcinoma of the prostate with neuroendocrine differentiation are not different from normal prostate adenocarcinoma 3,4 and therefore immunohistochemistry for the detection of neuroendocrine cells is not recommended in an otherwise typical adenocarcinoma of the prostate 2.
- 1. Fine SW. Neuroendocrine tumors of the prostate. (2018) Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc. 31 (S1): S122-132. doi:10.1038/modpathol.2017.164 - Pubmed
- 2. Epstein JI, Amin MB, Beltran H, Lotan TL, Mosquera JM, Reuter VE, Robinson BD, Troncoso P, Rubin MA. Proposed morphologic classification of prostate cancer with neuroendocrine differentiation. (2014) The American journal of surgical pathology. 38 (6): 756-67. doi:10.1097/PAS.0000000000000208 - Pubmed
- 3. Hu J, Han B, Huang J. Morphologic Spectrum of Neuroendocrine Tumors of the Prostate: An Updated Review. (2020) Archives of pathology & laboratory medicine. 144 (3): 320-325. doi:10.5858/arpa.2019-0434-RA - Pubmed
- 4. Kardoust Parizi M, Iwata T, Kimura S, Janisch F, Abufaraj M, Karakiewicz PI, Enikeev D, Rapoport LM, Hutterer G, Shariat SF. Focal Neuroendocrine Differentiation of Conventional Prostate Adenocarcinoma as a Prognostic Factor after Radical Prostatectomy: A Systematic Review and Meta-Analysis. (2019) International journal of molecular sciences. doi:10.3390/ijms20061374 - Pubmed